ArticleAntimicrobial agents and chemotherapy2025

The emerging concern of IMP variants being resistant to the only IMP-type metallo-β-lactamase inhibitor, xeruborbactam.

Christophe Le Terrier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.